143 related articles for article (PubMed ID: 11266555)
1. Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells.
Collis SJ; Tighe A; Scott SD; Roberts SA; Hendry JH; Margison GP
Nucleic Acids Res; 2001 Apr; 29(7):1534-8. PubMed ID: 11266555
[TBL] [Abstract][Full Text] [Related]
2. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
Wiechen K; Zimmer C; Dietel M
Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
[TBL] [Abstract][Full Text] [Related]
3. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
[TBL] [Abstract][Full Text] [Related]
4. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.
Dorai T; Olsson CA; Katz AE; Buttyan R
Prostate; 1997 Sep; 32(4):246-58. PubMed ID: 9288183
[TBL] [Abstract][Full Text] [Related]
5. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo.
Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC
Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.
Bindra RS; Schaffer PJ; Meng A; Woo J; Måseide K; Roth ME; Lizardi P; Hedley DW; Bristow RG; Glazer PM
Mol Cell Biol; 2004 Oct; 24(19):8504-18. PubMed ID: 15367671
[TBL] [Abstract][Full Text] [Related]
8. Impaired homologous recombination DNA repair and enhanced sensitivity to DNA damage in prostate cancer cells exposed to anchorage-independence.
Wang JY; Ho T; Trojanek J; Chintapalli J; Grabacka M; Stoklosa T; Garcia FU; Skorski T; Reiss K
Oncogene; 2005 May; 24(23):3748-58. PubMed ID: 15782124
[TBL] [Abstract][Full Text] [Related]
9. A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells.
Dorai T; Perlman H; Walsh K; Shabsigh A; Goluboff ET; Olsson CA; Buttyan R
Int J Cancer; 1999 Sep; 82(6):846-52. PubMed ID: 10446452
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
Chen Z; Ge Y; Landman N; Kang JX
BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
[TBL] [Abstract][Full Text] [Related]
11. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
13. Genetic re-engineering of Saccharomyces cerevisiae RAD51 leads to a significant increase in the frequency of gene repair in vivo.
Liu L; Maguire KK; Kmiec EB
Nucleic Acids Res; 2004; 32(7):2093-101. PubMed ID: 15087488
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
[TBL] [Abstract][Full Text] [Related]
15. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
18. Constructing the eukaryotic expression vector to study preliminarily the functions of hammerhead ribozyme targeting base excision repair gene HOGG1.
Zhang ZZ; Zhang Q; Wu M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):165-70. PubMed ID: 16608066
[TBL] [Abstract][Full Text] [Related]
19. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene.
Ohnishi T; Taki T; Hiraga S; Arita N; Morita T
Biochem Biophys Res Commun; 1998 Apr; 245(2):319-24. PubMed ID: 9571148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
